Home » Unicancer research » Unicancer R&D » Unicancer R&D publications

Unicancer R&D publications

Publications

2018

Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large ...

Elvire Pons-Tostivint et al, Annals of Surgical Oncology ; February 2019, Volume 26, Issue 2, pp 356–365

2018

Endocrine therapy or chemotherapy as first-line therapy in hormone receptorepositive HER2-negative metastatic breast ...

E Jacquet et al, European Journal of Cancer 95 (2018) 93e101.

2018

Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with ...

Luc Cabel et al, Breast Cancer Research and TreatmentJanuary 2019, Volume 173, Issue 2, pp 397–406.

2018

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

Elisa Gobbini et al, European Journal of Cancer 96 (2018) 17e24.

2018

Oral contraceptive use and breast cancer risk: retrospective and prospective analyses from a BRCA1 and BRCA2 ...

Lieske H. et al, JNCI Cancer Spectrum, Volume 2, Issue 2, 1 April 2018.

View all publications
Oral communications and posters

2018

Evaluation de l’intérêt de l’IRM corps entier pour la détection précoce des cancers chez les sujets porteurs de ...

O. Caron et al, Assises de Génétique Humaine et Médicale.

2018

Recommandation française du Groupe Génétique et Cancer pour l’analyse en panel de gènes dans le cadre de la ...

Jessica Moretta Serra et al, Assises de Génétique Humaine et Médicale.

2018

Intérêt du Vemurafenib chez les patients atteints d’une leucémie à tricholeucocytes (HCL) : résultats de l’étude de ...

X. Troussard et al, SFH.

2018

Genomic characterisation of metastatic breast cancer

F. André et al, SABCS

2018

Circulating ESR1 mutation detection rate and early decrease under first line aromatase inhibitor and palbociclib in ...

F.C. Bidard et al, SABCS

See all presentations